← Open Payments lookup

EMILY MARU: Open Payments

NPI 1578189650 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,394 in 86 payments from 24 companies in 2025. Trend: 2023 $709 · 2024 $1,429 · 2025 $2,394

Food & beverage: $2,339Education: $55
CompanyPaymentsAmount
Janssen Biotech, Inc.8$474
Sumitomo Pharma America, Inc.20$369
Bayer Healthcare Pharmaceuticals Inc.8$252
PFIZER INC.9$220
IMMUNITYBIO, INC.3$191
UROGEN PHARMA, INC.5$109
Novartis Pharmaceuticals Corporation3$91
TOLMAR, INC.4$87
ABBVIE INC.4$79
Merck Sharp & Dohme LLC3$75

Products named: ERLEADA, Nubeqa, GEMTESA, XTANDI, ANKTIVA, ORGOVYX, PLUVICTO, PYLARIFY.

Industry payments across MD — which companies pay providers there.